drugset / Trial / NCT00508040

Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a

NCT00508040

Phase 2 Completed 58 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedParallel-groupOpen-labelTreatment

Summary

Birdshot Retine choroidopathy (BRC) is a sight threatening posterior uveitis. The long term visual outcome has recently be studied showing a legal blindness to 14% at 5 years. Visual acuity is threatened by macular edema (80%), macular atrophy, and choroidal neovascularization.

Timeline

Start
2007-09
Primary completion
2011-10
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisone Other / unclassified
Subject interferon alfa Protein / enzyme biologic